Research

  • Hep B vaccine may lower diabetes risk, study suggests

    The hepatitis B vaccine appears to reduce the risk of diabetes by 15 per cent, even in people who have never been infected with the virus. The finding suggests the jab’s protective effect goes beyond preventing hepatitis B infection, which can impair the liver’s ability to regulate blood sugar. Researchers analysed health records from more [...]

  • Shingles jab may reduce risk of heart attack, study finds

    The shingles vaccine could lower the risk of heart attack or stroke by up to 20 per cent, according to the first global study of its kind. The jab was linked to an 18 per cent lower risk of stroke or heart attack in adults aged 18 and above, with a 16 per cent reduction [...]

  • Quick test could identify Alzheimer’s risk long before symptoms show

    A three-minute brainwave test can detect memory problems linked to Alzheimer’s disease long before typical diagnosis, raising hopes it could identify who may benefit from new drugs. The Fastball test uses electroencephalogram (EEG) sensors on the scalp to record electrical brain activity while people view images on a screen. It works by analysing automatic responses [...]

  • Business roundup: Grant to advance mitochondrial biomarker research

    Age Tech World explores the latest business developments in the world of ageing and longevity. Grant to advance groundbreaking mitochondrial biomarker research Countdown For A Cure, a foundation dedicated to accelerating mitochondrial research and medicine, has announced a US$350,000 grant to Minovia Therapeutics, a clinical-stage company pioneering mitochondrial transplantation technologies. The funding will support Minovia’s [...]

  • Participants sought for ‘groundbreaking’ dementia study

    The NHS is seeking nearly 200 people aged 45 and over to take part in a study that could enable earlier diagnosis of dementia through a blood test. The READ OUT study asks participants to give one 20ml blood sample and details of their medical history. Volunteers must either have been referred to memory services [...]

  • Long Covid causes effects similar to Parkinson’s or stroke, research reveals

    Long Covid patients face disability levels comparable to Parkinson’s or stroke survivors, with 86 per cent reporting significant limitations in daily life. The condition brings lasting fatigue, memory and concentration problems known as brain fog, breathlessness and reduced quality of life, often persisting for months or years after infection. Most people recover from Covid-19 after [...]

  • Omega-3 may protect women from Alzheimer’s disease

    Omega-3 fatty acids may help protect women from Alzheimer’s, offering clues as to why more women are diagnosed than men. Women with Alzheimer’s were found to have lower levels of unsaturated fats, especially omega fatty acids, compared with women without the disease. Researchers analysed brain inflammation and damage in plasma samples from 841 patients. The [...]

  • Older adults underestimate dangers of extreme heat, study finds

    Older adults often don’t realise how vulnerable they are to extreme heat and most aren’t prepared for long periods of hot weather, according to a review of more than 40 studies. In the review, researchers found that most studies focused on how older adults react when heat waves strike, such as staying hydrated or moving [...]

  • Animal protein not linked to higher mortality risk, study finds

    Eating animal-sourced protein foods is not linked to a higher risk of death and may even offer protective benefits against cancer-related mortality, new research has found The study analysed data from nearly 16,000 adults aged 19 and older using the National Health and Nutrition Examination Survey (NHAMES III). Researchers examined how much animal and plant [...]

  • Hormone breakthrough could pave way for next generation of weight loss drugs

    Scientists have uncovered how amylin hormone receptors work, a finding that may open the door to next-generation obesity drugs beyond today’s GLP-1 treatments like WeGovy and Ozempic. The research shows how amylin – a hormone that regulates appetite and blood sugar – activates three different receptors in the brain, each with distinct properties. For the [...]